コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 y receptors c-Fms (CSF-1 receptor) and RANK (receptor activator of nuclear factor kappaB).
2 ly decreased the gene copies of the biologic receptor activator of nuclear factor kappaB.
4 to the complex interactions of the OPG/RANKL/receptor activator of nuclear factor kappaB axis and tum
6 or, osteoprotegerin, or soluble forms of the receptor activator of nuclear factor-kappaB is able to p
9 age of a simplified system using recombinant receptor activator of nuclear factor kappaB ligand (RANK
10 have previously demonstrated that targeting receptor activator of nuclear factor kappaB ligand (RANK
11 IL-7 up-regulated T cell cytokines including receptor activator of nuclear factor kappaB ligand (RANK
12 athyroid hormone-related protein (PTHrP) and receptor activator of nuclear factor kappaB ligand (RANK
13 -6 (IL-6) and IL-15 and on the expression of receptor activator of nuclear factor kappaB ligand (RANK
15 w stromal cell cultures by inducing Cox2 and receptor activator of nuclear factor kappaB ligand (RANK
18 y-stimulating factor (M-CSF) and 50 ng/mL of receptor activator of nuclear factor kappaB ligand (RANK
21 ycoprotein that acts as a decoy receptor for receptor activator of nuclear factor kappaB ligand (RANK
23 ted from human monocytes with stimulation by receptor activator of nuclear factor kappaB ligand (RANK
24 ppressed TNF-induced tumor cell invasion and receptor activator of nuclear factor kappaB ligand (RANK
25 tion concurrent with increased expression of receptor activator of nuclear factor kappaB ligand (RANK
26 ammation alters bone mineral density involve receptor activator of nuclear factor kappaB ligand (RANK
28 n that numerous TNF family members including receptor activator of nuclear factor kappaB ligand (RANK
29 uced proinflammatory cytokine production and receptor activator of nuclear factor kappaB ligand + mac
30 ntiation, and bone resorption in response to receptor activator of nuclear factor kappaB ligand in vi
33 hese potential roles, clarify whether RANKL (receptor activator of nuclear factor kappaB ligand) prom
34 ) and a key regulator of osteoclastogenesis (receptor activator of nuclear factor kappaB ligand).
35 igational fully human monoclonal antibody to receptor activator of nuclear factor kappaB ligand, an e
36 (ODF; also known as osteoprotegerin ligand, receptor activator of nuclear factor kappaB ligand, and
37 ted by osteoprotegerin, a decoy receptor for receptor activator of nuclear factor kappaB ligand, and
38 Runx2 deficiency inhibited the expression of receptor activator of nuclear factor kappaB ligand, whic
39 onse in macrophages and completely inhibited receptor activator of nuclear factor kappaB ligand-depen
40 antiresorptive properties, ritonavir impairs receptor activator of nuclear factor kappaB ligand-induc
41 activator of nuclear factor kappaB receptor, receptor activator of nuclear factor kappaB ligand/macro
42 investigate their inhibitory effects on the receptor activator of nuclear factor- kappab ligand (RAN
43 ith macrophage colony-stimulating factor and receptor activator of nuclear factor-kappaB ligand (RANK
44 r necrosis factor family of ligands known as receptor activator of nuclear factor-kappaB ligand (RANK
45 er MIP-1alpha requires other factors such as receptor activator of nuclear factor-kappaB ligand (RANK
46 ology; by immunohistochemical examination of receptor activator of nuclear factor-kappaB ligand (RANK
48 ctor 2 (Runx2), fibromodulin, osterix, ki67, receptor activator of nuclear factor-kappaB ligand (RANK
49 munohistochemical analyses for detecting the receptor activator of nuclear factor-kappaB ligand (RANK
50 atase, is implicated in regulating M-CSF and receptor activator of nuclear factor-kappaB ligand (RANK
51 os of sclerostin, osteoprotegerin (OPG), and receptor activator of nuclear factor-kappaB ligand (RANK
52 The local expression of osteoclast effectors receptor activator of nuclear factor-kappaB ligand (RANK
54 ships between total oxidant status (TOS) and receptor activator of nuclear factor-kappaB ligand (RANK
55 hage colony-stimulating factor 1 (CSF-1) and receptor activator of nuclear factor-kappaB ligand (RANK
56 arrow cultures that were differentiated with receptor activator of nuclear factor-kappaB ligand (RANK
57 tartrate-resistant acid phosphatase (TRAP), receptor activator of nuclear factor-kappaB ligand (RANK
58 mation is regulated by balancing between the receptor activator of nuclear factor-kappaB ligand (RANK
59 f this study is to determine the role of the receptor activator of nuclear factor-kappaB ligand (RANK
60 iators of osteoclastic bone remodeling (e.g. receptor activator of nuclear factor-kappaB ligand (RANK
63 of macrophage colony-stimulating factor and receptor activator of nuclear factor-kappaB ligand (RANK
65 increased osteoclastogenesis in response to receptor activator of nuclear factor-kappaB ligand (RANK
66 is a fully human monoclonal antibody to the receptor activator of nuclear factor-kappaB ligand (RANK
67 ncer-induced osteolytic lesions, cleavage of receptor activator of nuclear factor-kappaB ligand (RANK
68 d others have previously shown that blocking receptor activator of nuclear factor-kappaB ligand (RANK
69 s the expression of the osteoclast activator receptor activator of nuclear factor-kappaB ligand (RANK
71 rease in osteoclast differentiation that was receptor activator of nuclear factor-kappaB ligand (RANK
73 es of healthy teeth (P = 0.003), and soluble receptor activator of nuclear factor-kappaB ligand (sRAN
74 are the local and systemic levels of soluble receptor activator of nuclear factor-kappaB ligand (sRAN
75 ular fluid (GCF) and serum levels of soluble receptor activator of nuclear factor-kappaB ligand (sRAN
76 d activation-induced cytokine, also known as receptor activator of nuclear factor-kappaB ligand (TRAN
77 clastogenesis and increase the expression of receptor activator of Nuclear factor-kappaB ligand and c
78 mitogen-activated protein kinase (p38), and receptor activator of nuclear factor-kappaB ligand and d
79 in conjunction with increased expression of receptor activator of nuclear factor-kappaB ligand and d
80 enotype to osteoclastic sensitization to the receptor activator of nuclear factor-kappaB ligand and i
81 and proteins involved in osteoclastogenesis (receptor activator of nuclear factor-kappaB ligand and o
82 review focuses on the roles of oxylipids and receptor activator of nuclear factor-kappaB ligand signa
83 d osteoclast differentiation and compromised receptor activator of nuclear factor-kappaB ligand signa
84 CXCL12-gamma fibroblasts upregulated RANKL (receptor activator of nuclear factor-kappaB ligand), con
85 actors macrophage colony-stimulating factor, receptor activator of nuclear factor-kappaB ligand, and
86 egulation of the osteoclast survival factor, receptor activator of nuclear factor-kappaB ligand, and
87 ttractant protein-1, P-selectin, fibrinogen, receptor activator of nuclear factor-kappaB ligand, high
88 b, a fully human monoclonal antibody against receptor activator of nuclear factor-kappaB ligand, on b
89 rs, including the soluble decoy receptor for receptor activator of nuclear factor-kappaB ligand, poss
90 osumab, a fully human monoclonal antibody to receptor activator of nuclear factor-kappaB ligand, supp
91 b, a fully human monoclonal antibody against receptor activator of nuclear factor-kappaB ligand, to p
92 parathyroid hormone-related protein but not receptor activator of nuclear factor-kappaB ligand, were
94 l cancer cells, preosteoclast migration, and receptor activator of nuclear factor-kappaB ligand-induc
95 that up-regulates Id2, the repressor of the receptor activator of nuclear factor-kappaB ligand-media
96 eated, bone-resorbing OCs (P < 0.00002) in a receptor activator of nuclear factor-kappaB ligand-media
98 further evidenced by increased expression of receptor-activator of nuclear factor-kappaB ligand (RANK
99 ged by colony stimulating factor (CSF)-1 and receptor-activator of nuclear factor-kappaB ligand (RANK
100 coadministration of 100-fold molar excess of receptor-activator of nuclear factor-kappaB ligand, anot
101 in osteoclast differentiation stimulated by receptor activator of nuclear factor kappaB-ligand (RANK
102 opoietic cells with EVs did not affect their receptor activator of nuclear factor kappaB-ligand (RANK
104 last differentiation signaling pathways, how receptor activator of nuclear factor kappaB (NF-kappaB)
108 rentiation markers when exposed to M-CSF and receptor activator of nuclear factor kappaB (RANK) ligan
109 we uncovered a potential mechanism by which receptor activator of nuclear factor kappab (RANK) ligan
110 trials with AMG-162, a human IgG2 that binds receptor activator of nuclear factor kappaB (RANK) ligan
111 over, we found that AMPKalpha1 inhibited the receptor activator of nuclear factor kappaB (RANK) signa
112 d -8), bone morphogenetic protein-2 (BMP-2), receptor activator of nuclear factor kappaB (RANK), RANK
113 e, elevated adenosine-A2AR signaling reduces receptor activator of nuclear factor kappaB (RANK)-media
115 nduced cytokine (TRANCE), and its receptors, receptor activator of nuclear factor-kappaB (RANK) and o
116 l signals from Toll-like receptors, CD40 and receptor activator of nuclear factor-kappaB (RANK) are i
117 sion of beta2-ARs, beta1-ARs, beta3-AR,s and receptor activator of nuclear factor-kappaB (RANK) in ca
119 f two tumour-necrosis-factor family members: receptor activator of nuclear factor-kappaB (RANK) ligan
120 wn-regulated the expression and secretion of receptor activator of nuclear factor-kappaB (RANK) ligan
122 eaction and immunohistochemical staining for receptor activator of nuclear factor-kappaB (RANK), RANK
124 ent assays to evaluate concentrations of the receptor activator of nuclear factor-kappaB (RANK), solu
126 eatment: CD30/CD30 ligand, CD40/CD40 ligand, receptor activator of nuclear factor-kappaB (RANK)/RANK
127 mediated mechanism that was inhibited by the receptor activator of nuclear factor-kappaB (RANK-Fc) in
131 In particular, osteoclasts resorb bone via a receptor activator of nuclear factor kappaB-receptor act
132 , nuclear factor of activated T-cells; RANK, receptor activator of nuclear factor-kappaB; T(CM), cent
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。